Monday, May 16, 2022 Agenda

Mon, May 16 at 11:00 am EDT
Welcome and Keynote - Paul C. Walker

Watch Session
Overview

If necessary, to view: Click the Activate button in the upper right corner (see screenshot below)

image

Session Agenda:

Welcome from our Conference Chair, Katie Nault 

Keynote address from incoming ASHP President, Paul C Walker. 

Paul C Walker, Pharm.D., FASHP, FMPA - Personal and Professional Leadership

Speaker(s)

Paul C. Walker, Pharm.D., FASHP, FMPA,

Platform Presentation Session 1

Mon, May 16 at 12:15 pm EDT
1 - Crystal A - Ambulatory Care

Watch Session
Overview
12:15 PMNicole Hughes Geisinger Clinic NortheastPrimary Care Pharmacists Impact on Vaccinations in the Geisinger Ambulatory Care Setting
12:30 PMSamantha Matchock Geisinger Clinic WestComparison of Effectiveness and Safety Outcomes in Patients with Dose Escalation of Empagliflozin in Practice
12:45 PMSteven Yost Conemaugh Memorial Medical CenterEvaluation of Pharmacist-Driven Diabetes Management in Lowering A1C Values
1:00 PMTimothy Amin The Brooklyn Hospital CenterPharmacist-led provider education to improve GLP-1 receptor agonist utilization in a family medicine clinic
1:15 PMViktoriya Avlasevich University of Rochester Medical CenterComparison of COVID-19 Infection Rates in Vaccinated and Unvaccinated Adult Patients with Autoimmune Inflammatory Disease on b/tsDMARD Therapy
1:30 PMAndrew Ward Backus HospitalImpact of pharmacist management of diabetes in the Backus Center of Endocrinology, Diabetes, and Metabolism
1:45 PMLazina Chowdhury Penn Presbyterian Medical CenterPharmacist-Led Vaccine Reconciliation in a Rheumatology Clinic
2:00 PMGurminder Sanghera Rochester General HospitalUse of Midodrine to Achieve Target Doses of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction

Mon, May 16 at 12:15 pm EDT
1 - Crystal B - Cardiovascular/Critical Care

Watch Session
Overview
12:15 PMLolade Bakare University of Rochester Medical CenterEffect of the COVID-19 pandemic on ICU Liberation Bundle adherence
12:30 PMRiley Goho Highland HospitalIdentification of Patients with Undertreated Lipids Post-Acute Coronary Syndrome
12:45 PMAlyssa Santos Saint Francis Hospital and Medical CenterEvaluation of Midodrine Use on Clinical Outcomes in Septic Shock
1:00 PMFrances Murray Dartmouth-Hitchcock Medical CenterEvaluation of Conversion Between P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Treated with PCI and Stenting
1:15 PMVictoria Plante Waterbury HospitalImplementation of a Multifaceted Quality Improvement Initiative on Adherence to Guideline-Directed Medical Therapy for Hospitalized Patients with Heart Failure
1:30 PMBrooke Kratz Hospital of the University of PennsylvaniaFour-Factor Prothrombin Complex Concentrate for Coagulopathy Following Aortic Surgery
1:45 PMLily Lin Shady Grove Adventist HospitalAssessing Appropriateness of Heparin Induced Thrombocytopenia Testing and Management in Two Community Hospitals
2:00 PMHannah Gilchrist Dartmouth-Hitchcock Medical CenterImpact on Diabetic Ketoacidosis (DKA) Resolution after Implementation of a Two Bag Fluid DKA Orderset

Mon, May 16 at 12:15 pm EDT
1 - Empire A - Cardiovascular/Critical Care

Watch Session
Overview
12:15 PMMeghan Cook, Brigham and Women's HospitalEvaluation of the timing of second doses of antibiotics in sepsis and septic shock
12:30 PMAlison Panchisin, York HospitalEvaluation of seizure prophylaxis in subarachnoid hemorrhage
12:45 PMIoannis Serris, Community Medical CenterA Pharmacist-Driven Ceftriaxone Dosing Protocol in Critically Ill Patients
1:00 PMMorgan Gentili, Lahey Hospital & Medical CenterEvaluation of Direct Oral Anticoagulant Prescribing for Venous Thromboembolism in Obesity and Cirrhosis
1:15 PMJennifer Bingham, Virginia Hospital CenterUtilization of phenobarbital loading dose compared to symptom-triggered dosing for severe alcohol withdrawal syndrome in a community hospital intensive care unit
1:30 PMDouglas DeSimone, Chester County HospitalOutcomes of a phenobarbital versus a benzodiazepine protocol for treatment of acute alcohol withdrawal in intensive care unit (ICU) patients
1:45 PMJohn Belardo, Virtua HealthDoes Dexmedetomidine Reduce Anxiolytic Use in Non-Intubated Patients?
2:00 PMOmar Alkhezi, Brigham and Women's HospitalEvaluation of dexmedetomidine safety in obese critically ill patients

Mon, May 16 at 12:15 pm EDT
1 - Empire B - Community Practice

Watch Session
Overview
12:15 PMIsabelle Litvak, Wilkes University, Nesbitt School of Pharmacy/Weis MarketsCommunity Pharmacists Perceptions' on Their Role in Counseling Patients on Lifestyle Modifications
12:30 PMIsabelle Dieu, Big Y/Western New England University College of Pharmacy and Health SciencesMarijuana Use Among People with Diabetes
12:45 PMJoseph Honig, University of Rhode Island College of Pharmacy / Rite AidA Pharmacist Driven Text-based Survey Network Pilot Project for Public Health and Legislative Advocacy Opportunities
1:00 PMMatthew Butler, University at Buffalo School of Pharmacy and Pharmaceutical SciencesIMPLEMENTING A SOCIAL DETERMINANTS OF HEALTH PROGRAM THROUGH THE LENS OF A WESTERN NEW YORK COMMUNITY PHARMACY
1:15 PMJemelia Scott, Bayhealth Medical CenterComparison of time within therapeutic range when a patient-specific nomogram versus a structured nomogram is utilized in outpatient warfarin management
1:30 PMPaige Gilk, Safeway Pharmacy/University of Maryland-Baltimore School of PharmacyEvaluation of Advanced Pharmacy Practice Experience Student Readiness and Willingness in Community-based Medication Administration
1:45 PMCourtney Quattrone, ACME Sav-on PharmacyImpact of Prescription Delivery Service on Patients Receiving their Influenza Vaccine in the Community Setting
2:00 PMChiamaka Adadey, Walgreens/Howard Community Pharmacy ResidencyPharmacy Personnel Perceptions of the Applicability of the American College of Cliincal Pharmacy (ACCP) "Template for Evaluating a Clinical Pharmacist" in the Community Pharmacy Setting

Mon, May 16 at 12:15 pm EDT
1 - Empire C - Emergency Medicine

Watch Session
Overview


12:15 PMEmily Farina, Robert Wood Johnson University HospitalEvaluating the Safety Outcomes Between Tenecteplase and Alteplase for Acute Ischemic Stroke: A Retrospective Cohort Study  
12:30 PMAnh Tieu, Lankenau Medical CenterEvaluation of efficacy and safety of four-factor prothrombin complex concentrate for the reversal of rivaroxaban-and-apixaban-associated major bleeding
12:45 PMTaylor Schliesser, Charleston Area Medical CenterIncidence of hyperglycemia after antipsychotic use for management of acute agitation in the emergency department
1:00 PMDaniel Cericola, University of Maryland Medical SystemVariable vs. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal
1:15 PMKate Lowrey, Christianna Care Health SystemEvaluation of the Efficacy and Utilization of Diabetic Ketoacidosis Protocol
1:30 PMJesse Lewandowski, Jersey Shore University Medical CanterEvaluating Emergency Department Prescribing Practices for Community Acquired Pneumonia (ED-CAP)
1:45 PMJoana Gjidede, St. Luke's University Health NetworkThe Impact of Morphine on Cardiovascular Outcomes in Patients with ST-Segment Elevation Myocardial Infarction (STEMI)
2:00 PMKarlee Deibler, Penn State Hershey Medical CenterDiltiazem Dosing for AFib with RVR in the Emergency Department

Mon, May 16 at 12:15 pm EDT
1 - Empire D - General Clinical Practice

Watch Session
Overview
12:15 PMMarina Youssef, Nazareth HospitalEvaluating the Impact of a Multidisciplinary Approach to Status Epilepticus Management Using Hospital Approved Guidelines
12:30 PMNiti Shah, Atlantic Health SystemEvaluation of Nurse-driven Unfractionated Heparin Nomogram in Non-obese and Obese Patients
12:45 PMAlyssa Bangrazi, Wentworth-Douglass HospitalComparison of phenobarbital versus benzodiazepines for the management of patients at high risk of alcohol withdrawal in a community hospital setting
1:00 PMSamantha Cammisa , Inspira Medical Center VinelandAUC Versus Trough Guided Monitoring of Intravenous Vancomycin and its Effects on Acute Kidney Injury
1:15 PMRyan Virgin, South County Hospital Healthcare SystemEvaluation of Inpatient Glycemic Control Pre- and Post-Implementation of a Hemoglobin A1c (HbA1c) Testing Protocol in a Small Community Hospital
1:30 PMSamantha Schermerhorn, Baystate Medical CenterImpact of Pharmacists Interventions on DOAC use Prior to Discharge
1:45 PMTyler Poli, Albany Medical Center HospitalHypoglycemia in Patients Receiving Sulfonylureas or Repaglinide During Inpatient Admission
2:00 PMKristen Fernandes, Massachusetts General HospitalPhenobarbital Concentration Correlation with Efficacy and Safety in Alcohol Withdrawal Syndrome

Mon, May 16 at 12:15 pm EDT
1 - Magnolia A - Infectious Disease

Watch Session
Overview

12:15 PMSheshadri Hoque, Charleston Area Medical CenterTime to De-escalation Post Accelerate Pheno System Implementation in Patients with Gram-negative Bacteremia
12:30 PMPeter Sung, Hospital of the University of PennsylvaniaCefpodoxime for SBP Prophylaxis: Incidence of Breakthrough Infections
12:45 PMAmandeep Kaur, Guthrie Robert Packer HospitalImproving Harm Reduction Services in People Who Inject Drugs at a Rural Health System
1:00 PMDanial Chowdhury, Monmouth Medical CenterA Prospective Analysis of a Pharmacist-Driven Drug Monitoring Program to Optimize Vancomycin Use in Patients with Bacteremia
1:15 PMMiranda Cason, St. Joseph's Regional Medical CenterDe-escalation of empiric vancomycin therapy after a negative nasal methicillin resistant staphylococcus aureus (MRSA) polymerase chain reaction (PCR) result in patients with suspected pneumonia
1:30 PMTrent Gray Jr., York HospitalCODEWAR: The Impact of COVID-19 on Warfarin Anticoagulation Requirements
1:45 PMReid LaPlante, University of Maryland Medical SystemReview of Positive Post-Discharge Sterile-site Cultures at UMMC: Evaluation of the Frequency of Ineffective Therapy and Provider Follow-up and the Impact on Infection-Related Complications
2:00 PMJasmine Elabed, Berkeley Medical CenterEvaluation of AKI and Therapeutic Efficacy in Traditional Vancomycin Dosing Compared to Vancomycin AUC Dosing in a Community Hospital

Mon, May 16 at 12:15 pm EDT
1 - Magnolia B - Infectious Disease

Watch Session
Overview
12:15 PMMadiha Faruqi, Paoli HospitalEvaluating the Clinical Utility of Prophylactic Antibiotics in the Management of Traumatic Facial Fractures
12:30 PMJessica Spangler, Backus HospitalEvaluation of automated blood culture reports with real-time notification and subsequent pharmacist intervention on time to optimal therapy in patients with bacteremia
12:45 PMCarolin Tran, Bon Secours Memorial Regional Medical CenterPLATEAU Trial: Procalcitonin Levels in Patients with Renal Dysfunction
1:00 PMNancy Reid, Winchester Medical CenterBaricitinib versus tacilizumab for the treatment of moderate to severe COVID-19
1:15 PMDaniel Mesa, SUNY Health Science Center at Brooklyn University HospitalEffects of rapid initiation of antiretroviral therapy on viral suppression and retention of care
1:30 PMSarah Cruz, Veterans Affairs Connecticut Healthcare SystemImplementation of a standardized process for outpatient COVID-19 treatments at a Veterans Affairs (VA) hospital
1:45 PMSkyee Edwards, West Virginia University MedicineEvaluation of surgical site infections in postoperative patients with a documented beta lactam allergy
2:00 PMMatty Zimmerman, The Johns Hopkins HospitalDefining Effective Treatment Durations for Patients with Bloodstream Infections caused by Non-Fermenting Gram-Negative Bacteria: A Multicenter Observational Study

Mon, May 16 at 12:15 pm EDT
1 - Magnolia C - Medication Safety

Watch Session
Overview
12:15 PMJoy Leonard, Sibley Memorial HospitalEnhancing pharmacovigilance methodologies in infusion center oncology patients
12:30 PMVictoria Fazio, JFK Medical CenterSafety and Feasibility of Opening Tamsulosin Capsules for Enteral Feeding Tube Administration
12:45 PMLjubica Minova, Saint Barnabas Medical CenterPharmacist consult service in patients with acute hospitalization greater than 30 days
1:00 PMBriannan Budzak, Geisinger Community Medical CenterEvaluating Hypoglycemic Events in a Critical Care Insulin Infusion Protocol Compared to a Basal-Bolus Insulin Regimen
1:15 PMNaomi Greenwood, Maine General Medical CenterCreating a Pharmacist-driven Nasal Naloxone Take-Home Kit protocol for a rural community hospital
1:30 PMJayson Jessup, Tabula Rasa HealthCareComparison of drug interactions identified by three software in medically-complex older adults
1:45 PMCaitlyn Blake, Christianna Care Health SystemInsulin Prescribing Errors at Transitions of Care and the Impact on Readmission Rates
2:00 PMAlmas Hussain, Southside HospitalImpact of a Health System Implemented Dosing Methodology on Appropriate Prescribing of Direct Oral Anticoagulants

Mon, May 16 at 12:15 pm EDT
1 - Magnolia D - Pediatrics

Watch Session
Overview
12:15 PMBrianna Wheeler, Wentworth-Douglass HospitalEffect of the Eat, Sleep, Console Model of Care on Total Morphine Administration to Narcotic or Substance Exposed Infants
12:30 PMAlyssa Ragno, Saint Peter's University HospitalEvaluation of high-dose methotrexate practices for pediatric oncology patients a community teaching hospital
12:45 PMSara Frey, Lehigh Valley Health NetworkEvaluation of the Non-pulmonary Benefits after Initiation of Trikafta (elexacaftor/tezacaftor/ivacaftor)
1:00 PMAlexis Duncan, Tufts Medical CenterDevelopment and Implementation of a Structured Pharmacist-Driven Medication Discharge Program for Pediatric Patients
1:15 PMAndrew Sweigart, The Children's Hospital of  PhiladelphiaEvaluation of the Use of Naltrexone for Cholestatic Pruritus
1:30 PMHeather Honor, Dartmouth-Hitchcock Medical CenterImplementation of Pediatric Standard Concentrations at a Critical Access Hospital
1:45 PMMaria Sedky Saad, New York-Presbyterian HospitalMycophenolate dosing strategy and therapeutic drug monitoring relationship to outcomes in pediatric solid organ transplant
2:00 PMKelsie Friedson, The Children's Hospital of PhiladelphiaSafety and Efficacy of Methylnaltrexone for Opioid Induced Constipation

Mon, May 16 at 12:15 pm EDT
1 - Wild Rose A - PK 1/Drug & Poison Info/Investig Drug

Watch Session
Overview
12:15 PMClairessa Ciupak, Olean General HospitalMonoclonal antibodies may reduce return visits to the Emergency Room and hospital admissions for SARS-CoV-2
12:30 PMVivian Nguyen, The Johns Hopkins HospitalOptimization of Regulatory Compliance and Drug Distribution Practices within a Clinical Research Network
12:45 PMHanyu Dai, Baystate Medical CenterIncreasing Naloxone Access for Inpatients at High Risk of Opioid Overdoses
1:00 PMJon Jasko, West Virginia University MedicineComparison of unfractionated heparin dosing strategies used in transcatheter aortic valve replacement (TAVR)
1:15 PMMay Nicholson, Riverside Regional Medical CenterEvaluating effectiveness of two dosing strategies at achieving initial therapeutic serum levels of vancomycin in adult patients: comparing protocol-based dosing versus patient-specific pharmacokinetic/pharmacodynamics dosing
1:30 PMAndrea Harmon, Marshall University School of Pharmacy/King's Daughter's Medical CenterImplementation and Assessment of Vancomycin AUC Dosing and Monitoring
1:45 PMAsma Husna, Greater Baltimore Medical CenterEfficacy and safety of a vancomycin dosing and monitoring protocol based on the area under the curve/minimum inhibitory concentration ratio at a community hospital
2:00 PMSavan Patel, Robert Wood Johnson University Hospital - SOMERSETImproving Safety of Cefepime Dosing in the Critically Ill Patient Using a Population Pharmacokinetic Approach

Mon, May 16 at 12:15 pm EDT
1 - Wild Rose B - Practice Research

Watch Session
Overview
12:15 PMJacob Greenwald, Walgreens Western New England University COPAssessing Vaccine Hesitancy of Adults ages 27-45 years Towards Human Papillomavirus (HPV) Immunization
12:30 PMVictoria Fusco, MedStar Union Memorial HospitalPilot study of medication contribution to inpatient falls at two community hospitals
12:45 PMShawntel Brown, Bayhealth Medical Center“Assessing the impact of clinical pharmacist team members on medication related problems in an inpatient rehabilitation unit”
1:00 PMNoah Yoo, JFK Medical CenterA Single Dose of Sodium Zirconium Cyclosilicate versus Sodium Polystyrene Sulfonate for the Treatment of Acute Hyperkalemia
1:15 PMDaniel Skoloda, The Johns Hopkins HospitalPerception of Varenicline Prescribing in Psychiatric Comorbidities
1:30 PMJennifer Gaquin, Anne Arundel Medical CenterUtility of methicillin-resistant S. aureus nares screening in patients with febrile neutropenia and implications for antimicrobial stewardship
1:45 PMAngela Liu, Montefiore Medical CenterOptimal timing of filgrastim initiation after autologous hematopoietic cell transplantation

Break    2:15 PM - 2:45 PM

Platform Presentation Session 2

Mon, May 16 at 2:45 pm EDT
2 - Crystal A - Ambulatory Care

Watch Session
Overview
2:45 PMLauren Cline, Kaiser PermanenteSafety and effectiveness of direct oral anticoagulants in patients with a creatinine clearance less than 30 ml/min
3:00 PMAnna Mortali, Baystate Medical CenterPharmacist Impact on Improving A1C and Hypertension in an Ambulatory Care Setting
3:15 PMKate Meyer, The Brooklyn Hospital CenterEvaluation of Pharmacists-led Lipid Lowering Interventions for Secondary ASCVD Prevention in HIV+ Patients
3:30 PMAarezo Riaz, Valley HospitalEvaluating the Impact of Embedding an Ambulatory Care Pharmacist in an Outpatient Cardiology Clinic
3:45 PMMichael Ghizzoni, Lebanon Veterans Affairs Medical CenterDevelopment of a Whole Health Pathway for Patients with Diabetes
4:00 PMFaith Babowicz, The University of Vermont Medical CenterIncidence of and Risk Factors for Drug Induced Liver Disease in Adults with Cystic Fibrosis Taking Elexacaftor/Tezacaftor/Ivacaftor
4:15 PMMichelle Azar, The Johns Hopkins HospitalAssessing an Anticoagulation Bridging Service in a Perioperative Interdisciplinary Clinic
4:30 PMMichael Maiullari, Cambridge Health AllianceImpact of targeted medication reviews to assess appropriate initiation of SGLT2-i and/or GLP-1 agonists in patients with type 2 diabetes mellitus who have compelling indications
Speaker(s)

Lauren Cline,

Anna Mortali,

Kate Meyer,

Aarezo Riaz,

Michael Ghizzoni,

Faith Babowicz,

Michelle Azar,

Michael Maiullari,

Heather Scheckner,

Gabrielle Plaia,

Mon, May 16 at 2:45 pm EDT
2 - Crystal B - Cardiovascular/Critical Care

Watch Session
Overview
2:45 PMMegan Hastings , Virtua HealthEvaluation of the Treatment for Diabetic Ketoacidosis at a Community Health System in the Intensive Care Unit
3:00 PMAli Althubyani, Steward St. Elizabeth's Medical Center of BostonThe Effect of Adjunct Inhaled Epoprostenol on Improving Oxygenation in Critically Ill Patients with Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Infection
3:15 PMStephanie Jackson , Meritus Medical CenterEvaluation of Melatonin Versus Standard Care in the Prevention of Delirium in Critical Care Patients of a Community Hospital
3:30 PMNgozika Odigbo, University of Maryland Medical SystemEvaluation of Venous Thromboembolism Prophylaxis in Trauma Patients
3:45 PMBrittany Block, University of Massachusetts Memorial Medical CenterSafety and efficacy of cangrelor versus eptifibatide in neuroendovascular patients at a comprehensive stroke center
4:00 PMJennifer Dolphin, Thomas Jefferson University HospitalAssessment of safety of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and renal failure
4:15 PMAngela Dansereau, Hartford HospitalEvaluation of the safety and efficacy of peripheral vasopressors to decrease central line placement and associated bloodstream infections
4:30 PMKayla Berry, Johns Hopkins Bayview Medical CenterEvaluation of Bivalirudin Weight-based Dosing in Obese Patients
Speaker(s)

Megan Hastings,

Ali Althubyani,

Stephanie Jackson,

Ngozika Odigbo,

Brittany Block,

Jennifer Dolphin,

Angela Dansereau,

Kayla Berry,

Kelsey Schrader,

Michelle Centrella,

Mon, May 16 at 2:45 pm EDT
2 - Empire A - Cardiovascular/Critical Care

Watch Session
Overview
2:45 PMKaitlin Armstrong, Hospital of Central ConnecticutImpact of Clevidipine versus Nicardipine on Time in Range when Lowering Blood Pressure
3:00 PMAlexis Small, Portsmouth Regional HospitalComparison of Tenecteplase vs. Alteplase in the setting of acute ischemic stroke
3:15 PMThuyDuong (June) Tran, John Dempsey Hospital at the University of Connecticut Health CenterNicardipine versus clevidipine in hypertension emergency and stroke outcomes
3:30 PMUyen Luong, Martinsburg Veterans Affairs Medical CenterEvaluation of exposure to selective serotonin reuptake inhibitors and the development of myocardial infarction or cerebrovascular accident
3:45 PMLama Alfehaid, Beth Israel Deaconess Medical CenterEvaluation of Anti-Xa-Guided versus aPTT-Guided Management of Intravenous Unfractionated Heparin in Patients Requiring a Durable Ventricular Assist Device (VAD)
4:00 PMJu Hee Kim, Massachusetts General HospitalAnalysis of the Use of Empiric Antimicrobial Prophylaxis for Temporary Cardiac Devices at a Large Academic Medical Center
4:15 PMScott Alexander, Geisinger Lewistown HospitalDifference in Venous Thromboembolism Rate of non-Critically Ill COVID-19 Patients Based on Demographic Risk Factors
4:30 PMRachel Seidel, Geisinger Medical CenterTiming of Deep Vein Thrombosis Prophylaxis After Traumatic Intracranial Hemorrhage

Speaker(s)

Kaitlin Armstrong,

Alexis Small,

ThuyDuong (June) Tran,

Uyen Luong,

Lama Alfehaid,

Ju Hee Kim,

Scott Alexander,

Rachel Seidel,

Natalya Asipenko,

Brian Carlone,

Mon, May 16 at 2:45 pm EDT
2 - Empire B - DSM/Outcomes

Watch Session
Overview



2:45 PMKaitlyn Kenjesky, Veterans Affairs Boston HealthcareApplication of a Pharmacist Designed Clinical Template to Assist in Pharmacogenomic (PGx) Guided Pharmacotherapy in a Veteran Population at VA Boston Healthcare System (VABHS)
3:00 PMPaul Papi, Wilkes-Barre Veterans Affairs Medical CenterImpact of FreeStyle Libre Continuous Glucose Monitor Systems on Diabetes Outcomes
3:15 PMHaley Evans, Kaiser PermanenteThe Physician Approval Rates of Alternative Medication Therapy Management from Criteria Based Consultation Reviews Before and After the Implementation of the Physician Champions Program
3:30 PMMatthew Dacey, Wilkes-Barre Veterans Affairs Medical CenterImpact of Pharmacist Intervention on Inhaled Corticosteroid De-escalation in Patients with Chronic Obstructive Pulmonary Disease
3:45 PMReemal Zaheer, Johns Hopkins Home Care GroupImpact of COVID-19 on prescribing patterns of disease modifying therapies (DMTs) in multiple sclerosis
4:00 PMShivangi Patel, Holy Cross HealthAssessment of the Impact of Clinical Interventions Made By Pharmacists on Hospital Length of Stay
4:15 PMHope Mae Abarintos, University of Rochester Medical CenterImpact of dexmedetomidine use on the incidence of hypertension following repair of coarctation of the aorta repair
4:30 PMCourtney Cameron, Boston Medical CenterIncreasing Pharmacist Anticoagulation Clinic Referral Following DOAC Initiation in the Hospital
Speaker(s)

Kaitlyn Kenjesky,

Paul Papi,

Haley Evans,

Matthew Dacey,

Reemal Zaheer,

Shivangi Patel,

Hope Mae Abarintos,

Courtney Cameron,

Kristin Reindel,

Casandra Holveck,

Mon, May 16 at 2:45 pm EDT
2 - Empire C - Education

Watch Session
Overview
2:45 PMAlyssa White, Veterans Affairs Maine Healthcare SystemReal World Outcomes of Biosimilar Conversations at VA Maine Healthcare System
3:00 PMLeigh Mathieu, Veterans Affairs Maine Healthcare SystemImpact of a Multi-Disciplinary Virtual Heart Failure Clinic on Veterans with Heart Failure with Reduced Ejection Fraction
3:15 PMBasem Elashal, Hunterdon Medical CenterEvaluation of telephonic vs in-person medication counseling on patient satisfaction
3:30 PMHillary Mishcon, Veterans Affairs Maine Healthcare SystemImpact of pharmacist driven interventions on benzodiazepine use in at risk veteran populations
3:45 PMAvery Hassey, Abington Memorial HospitalAcceptance of Nicotine Replacement Therapy for Patients on an Inpatient Psychiatric Unit after Pharmacist Adherence Counseling
Speaker(s)

Alyssa White,

Leigh Mathieu,

Basem Elashal,

Hillary Mishcon,

Avery Hassey,

Emily Stoukides,

Kevin Chamberlin,

Mon, May 16 at 2:45 pm EDT
2 - Empire D - Emergency Medicine

Watch Session
Overview
2:45 PMFaith Peters, Marshall University School of Pharmacy/King's Daughter's Medical CenterImproving utilization of an alternative to opiods order set in the emergency department of a tristate hospital
3:00 PMAkta Patel, Pennsylvania Hospital part of University of Pennsylvania Health Care SystemEvaluation of Geriatric Patients in the Emergency Department Prescribed Potentially Inappropriate Medications Upon Discharge
3:15 PMKarch Helsel, Conemaugh Memorial Medical CenterPharmacist Impact on Tissue Plasminogen Activator Administration Time in Stroke Response
3:30 PMJeff Kamta, University of Rochester Medical CenterEvaluation of hydroxocobalamin use for the treatment of suspected cyanide toxicity secondary to smoke inhalation
3:45 PMStephen McAllister, Temple University HospitalAnalysis of the Impact of Analgosedation in the Emergency Department
4:00 PMJennifer Ngo, Bon Secours Memorial Regional Medical CenterNaloxone Prescribing in the Emergency Department
4:15 PMHeba Hezzini, Jersey City Medical CenterDon't Bite the Hand that Feeds You Optimizing the use of rabies vaccine and immunoglobulin
4:30 PMChaya Lachman, Carroll Hospital CenterTackling unnecessary use of rabies post-exposure prophylaxis in the emergency department
Speaker(s)

Faith Peters,

Akta Patel,

Karch Helsel,

Jeff Kamta,

Stephen McAllister,

Jennifer Ngo,

Heba Hezzini,

Chaya Lachman,

Justin Miller,

Jennifer Silva,

Mon, May 16 at 2:45 pm EDT
2 - Magnolia B - Infectious Disease

Watch Session
Overview


2:45 PMSamantha Sallerson, The Unity Hospital of RochesterEvaluation of MRSA surveillance on the empiric treatment of pneumonia at a community teaching hospital
3:00 PMAndrew Hepler, Summit HealthDaptomycin Substituted for Vancomycin in Skin and Skin Structure Infections: An Assessment of Clinical Outcomes and Cost
3:15 PMRomina Javadi, St. Barnabas - BronxImpact of a Pharmacy-Driven Vancomycin Monitoring Program at SBH Health System
3:30 PMThuan Tran, Cambridge Health AllianceThe Nose Knows: Utility of MRSA Nasal PCR Screening for Antimicrobial Stewardship at Two Community-Teaching Hospitals
3:45 PMAnna Chen, James J Peters Veterans Affairs Medical CenterTiming of corticosteroid initiation in relation to symptom onset in severe COVID-19
4:00 PMMichael Lichardi, Ocean University Medical CenterEvaluation of a Pharmacist to Dose Vancomycin Pilot Program in a University Medical Center Critical Care Unit
4:15 PMAndrew Wallin, Englewood Hospital and Medical CenterCasirivimab plus Imdevimab versus Bamlanivimab Monotherapy versus Bamlanivimab plus Etesevimab: Effect on 30-day Hospitalizations for COVID-19 at a Community Hospital
4:30 PMSydney Petersen, West Virginia University MedicineFrequency of therapeutic drug monitoring and occurrence of acute kidney injury (AKI) for patients receiving vancomycin on an outpatient parenteral antibiotic therapy (OPAT) program

Speaker(s)

Samantha Sallerson,

Andrew Hepler,

Romina Javadi,

Thuan Tran,

Anna Chen,

Michael Lichardi,

Andrew Wallin,

Sydney Petersen,

Alexander Cain,

Alice Hsu,

Mon, May 16 at 2:45 pm EDT
2 - Magnolia C - Infectious Disease

Watch Session
Overview
2:45 PMSuchi Shah, Bon Secours Memorial Regional Medical CenterDetermination of Multidrug Resistant Pathogen Risk Factors in Community Acquired Pneumonia Patients
3:00 PMAlexa Flood, Veterans Affairs New Jersey Health Care SystemEvaluating Weight Gain in Dolutegravir-Based Antiretroviral Therapy Without Concomitant Tenofovir Alafenamide
3:15 PMMukundwa Gael, The Johns Hopkins HospitalCharacteristics of Bloodstream Infections in Cardiac Surgery Patients
3:30 PMChristian Macaspac, Veterans Affairs Maryland Healthcare BaltimoreCharacterizing the use of Bismuth-based Therapy for Helicobacter pylori at a Veterans Affairs Medical Center
3:45 PMRachel Cruickshank, Charleston Area Medical CenterEvaluation of antimicrobial stewardship when using BioFire FilmArray Pneumonia Panel
4:00 PMChantal Zony, Saint Joseph Medical CenterAssessment of antimicrobial prescribing patterns in patients with asymptomatic bacteriuria in a community teaching hospital.
4:15 PMPatrick Watchorn, Penn State Hershey Medical CenterRetrospective review of single dose piperacillin-tazobactam effect on reduction of central line-associated bloodstream infections following alteplase administration
4:30 PMNicole Tokatli, University of Massachusetts Memorial Medical CenterPractical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares PCR Screening to Support Antimicrobial Stewardship Efforts for Vancomycin De-escalation at a Tertiary Medical Center
Speaker(s)

Suchi Shah,

Alexa Flood,

Mukundwa Gael,

Christian Macaspac,

Rachel Cruickshank,

Chantal Zony,

Patrick Watchorn,

Nicole Tokatli,

Elisa Morgan,

Aiman Bandali,

Mon, May 16 at 2:45 pm EDT
2 - Magnolia D - Oncology

Watch Session
Overview
2:45 PMAllison Mueller, James J Peters Veterans Affairs Medical CenterImpact of Statins on Cardiovascular Outcomes in Veterans with Prostate Cancer Receiving Abiraterone or Enzalutamide
3:00 PMJulia Fadul , University of Rochester Medical CenterRisk Factors for Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Undergoing Induction Chemotherapy: A Case-Control Study
3:15 PMAmanda Hutchinson, Emerson HospitalSame-day versus next-day administration of pegfilgrastim in neutropenia prevention
3:30 PMLina Shao, Reading HospitalRisk of Pulmonary Toxicity when Utilizing Granulocyte Colony-Stimulating Factors with Bleomycin Treatment
3:45 PMMadison Walling, West Virginia University MedicineEvaluation of the occurrence and factors for spontaneous cytomegalovirus clearance after low level reactivation using a pre-emptive treatment threshold of 4,000 IU/mL in allogeneic hematopoietic cell transplant recipients
4:00 PMSrivarshini Kanukollu, Hackensack University Medical CenterImpact of Steroid Prophylaxis on Engraftment Syndrome Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant
4:15 PMHumam Alkhaled, MedStar Washington Hospital CenterMarijuana and Dietary Supplement Use in African-American Hemotology/Oncology Patients
4:30 PMMelissa Gallo, Highland HospitalReal world use of venetoclax in combination with a hypomethylating agent or low-dose cytarabine for myeloid leukemias at an academic medical center
Speaker(s)

Allison Mueller,

Julia Fadul,

Amanda Hutchinson,

Lina Shao,

Madison Walling,

Srivarshini Kanukollu,

Humam Alkhaled,

Melissa Gallo,

Quan Li,

Erin Rogers,

Mon, May 16 at 2:45 pm EDT
2 - Wild Rose A - Pain Mgmt/Palliative Care

Watch Session
Overview
2:45 PMSara Hall, Sinai Hospital of BaltimoreEfficacy of the utilization of ketamine for pain management in critically ill adult patients
3:00 PMChristina Topalidis, Hospital of the University of PennsylvaniaOpioid-induced sedation monitoring on general inpatient units at an acute care hospital
3:15 PMMatthew Kuhn, Coatesville VAMCIdentification and Risk Mitigation of Veterans on Gabapentinoids at High Risk for Respiratory Depression at CVAMC
3:30 PMMiriam Uchendu, Moses Taylor HospitalEvaluating a multimodal approach to pain management in Enhanced Recovery after Cesarean Section (ERAC) at a community Hospital
3:45 PMAdwoa Nyame, Johns Hopkins Bayview Medical CenterEvaluation of Pain Management in Patients with Cancer and Substance Use Disorder
4:00 PMAlexander Haines, Lancaster General HospitalAcute Pain Management for Patients on Buprenorphine for Medication-Assisted Therapy
4:15 PMNgan Nguyen, St. Mary's Medical CenterThe Impact of a Postoperative Cardiothoracic (CT) Surgery Pain Management Order Set on Morphine Equivalent Daily Dose (MEDD)
Speaker(s)

Sara Hall,

Christina Topalidis,

Matthew Kuhn,

Miriam Uchendu,

Adwoa Nyame,

Alexander Haines,

Ngan Nguyen,

Nancy Love,

Alicia Large,

Mon, May 16 at 2:45 pm EDT
2 - Wild Rose B - Psychopharmacology

Watch Session
Overview
2:45 PM Theresa Nguyen, UPMC Pinnacle Harrisburg Experience with brexanolone for the treatment of postpartum depression at a community teaching hospital
3:00 PMEmily Fedor, Veterans Affairs Connecticut Healthcare SystemUtilization of medications to treat alcohol use disorder at a Veteran's affairs medical facility
3:15 PMVictoria Downs, Washington DC VAMCPharmacotherapy Optimization for Alcohol Use Disorder Upon Pharmacist Recommendation and Implementation within the VA Population (POUR)
3:30 PMCaralyn Granato, Providence Veterans Affairs Medical CenterEvaluation of the association between cannabis use and a measure of PTSD symptom severity in a veteran population
3:45 PMArielle Norton, Veterans Affairs Connecticut Healthcare SystemCreation and Implementation of an Agitation Order Set
4:00 PMStephanie Rouvalis, St. Vincent's Medical CenterEvaluation of Melatonin in Reducing Antipsychotic Use in Geriatric Patients
4:15 PMStephen Parker, Gulf Coast Veterans Health Care SystemDevelopment and Implementation of a Long-Acting Partial Opioid Agonist Injectable Procedure at a Veterans Affairs Medical Center
Speaker(s)

Theresa Nguyen,

Emily Fedor,

Victoria Downs,

Caralyn Granato,

Arielle Norton,

Stephanie Rouvalis,

Stephen Parker,

Peter Wirkowski,

Cristina Madden,